Modulating endoplasmic reticulum stress attenuates mast cell degranulation

Jialiang Fan,Longpeng Ma,Bailing Xie,Shuyao Qiu,Shuo Song,Zhiyuan Tang,Yongjin Wu,Hui Huangfu,Yan Feng,Xiangqian Luo,Pingchang Yang
DOI: https://doi.org/10.1016/j.intimp.2023.111336
IF: 5.714
2023-12-08
International Immunopharmacology
Abstract:Objectives Degranulation of mast cells leads to direct allergic symptoms. The underlying mechanism needs to be explored further. Endoplasmic reticulum (ER) stress is involved in the pathogenesis of allergic conditions. The objective of this study is to gain a better understanding of the mechanism of mast cell degranulation. Methods Bone marrow derived mast cells and mast cells isolated from the airway tissues were prepared. The role of ER stress in mediating the release of mast cells was tested. RNA sequencing (RNAseq) was used to investigate the genetic activities of mast cells. Results Our observation showed that sensitization increased ER stress in mast cells. X-box-1 binding protein (XBP1) activity was linked to mast cell degranulation. Modulation of ER stress or XBP1 expression regulates the release of the mast cell mediator. XBP1 promoted the mediator release of mast cells by activating spleen tyrosine kinase (Syk). Activation of eukaryotic initiation factor 2a (eIF2a) inhibited XBP1 in mast cells. Semaphorin 3A was effective in preventing experimental allergic rhinitis (AR) due to its ability to suppress the release of mast cell mediators. Conclusions ER stress is associated with the mast cell degranulation. By inhibiting XBP1, the crucial molecule of ER stress, mast cell degranulation can be suppressed and experimental AR can be mitigated.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?